FDA Announces Phase-Out of Animal Models and Incentives for Use of New Emerging Methodologies (NAMs) in Preclinical Studies for Monoclonal Antibodies. Read the Post.
Phase Advance Technology Powers In Silico Clinical Trial of Common Antibiotic for Life-Threatening Lung Disease. Read Press Release.
Phase Advance AI Cofounder Dr. Tawanda Gumbo to speak at ACoP 2024, Nov 10 – 13th, on “AI-aided Virtual Disease Progression Clinical Trials – The marriage of nonlinear mathematical modeling, biology, and AI in predicting future individual patient responses in global health”. Learn More.
